logo

For the Inventor, By the Inventor

Denver, CO, United States of America

Accera, Inc.

Calculating rank
USPTO Granted Patents = 11

% Expired Patents = 45.5


Trademarks = 3

Forward Citations = 411

Loading Chart...
Loading Chart...

1 inventor (with patents filed for the assignee):

goldMedal Samuel T Henderson (11 out of 14 patents)


11 patents:

1. 10111849 - Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism II (2018-10-30),
2. 10105338 - Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function (2018-10-23),
3. 9603823 - Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism II (2017-03-28),
4. 9175345 - Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function (2015-11-03),
5. 9125881 - Monoglyceride of acetoacetate and derivatives for the treatment of neurological disorders (2015-09-08),
6. 8748400 - Use of ketogenic compounds for treatment of age-associated memory impairment (2014-06-10),
7. 8445535 - Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism II (2013-05-21),
8. 8426468 - Use of medium chain triglycerides for the treatment and prevention of alzheimer'S disease and other diseases resulting from reduced neuronal metabolism (2013-04-23),
9. 8124589 - Use of ketogenic compounds for treatment of age-associated memory impairment (2012-02-28),
10. 8105809 - Enzymatic synthesis of acetoacetate esters and derivatives (2012-01-31),
11. 6835750 - Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II (2004-12-28),
Company Overview
Accera, Inc. is a biotechnology company based in Denver, Colorado, focused on developing innovative therapies for neurodegenerative diseases. The organization specializes in creating solutions aimed at improving cognitive function and overall brain health. Accera's research primarily revolves around metabolic approaches to address conditions such as Alzheimer's disease, leveraging a deep understanding of the underlying biological mechanisms. Through its commitment to scientific advancement, Accera aims to enhance the quality of life for individuals affected by these challenging disorders.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

11 Patents

#94 in Denver, CO

#583 in Colorado

#27,540 in US

#51,831 in the World

Denver, CO (US)
Denver, CO, United States of America

Accera, Inc.

Forward Citations = 411

1 inventor:

goldMedal Samuel T Henderson (11 out of 14 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Accera, Inc.. Retrieved from https://idiyas.com/company/accera

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…